Data-Driven Toxicity Prediction: Advances in Machine Learning, DeepLearning, and Predictive Tools - A Systematic Review

INTRODUCTION/OBJECTIVE: High rate of attrition still inhibits drug discovery and development, with toxicity accounting for one of the primary causes of failure in preclinical and clinical development. This review summarizes Machine Learning (ML), Deep Learning (DL), and emerging post-deep learning strategies in drug discovery and environmental safety. METHODS: Following PRISMA guidelines, a systematic search was conducted across PubMed, Web of Science, Scopus, and ScienceDirect for the years 2015-2025, yielding 1,020 articles. Additional records were obtained from Google Scholar and the reference lists of about 60 articles. The studies were included when they used ML/DL to predict toxicity, provided quantitative measures of performance (e.g., accuracy, AUC, F1-score), or when they described the predictive tools and platforms. Eligibility criteria were: the study was entirely experimental toxicology with no computational modeling of the study, lacked an adequate description of the methodology, or was in a non- English language. The last study count of the paper is 50 articles. RESULTS: DL models like convolutional and graph neural networks are more effective in cases when the size of the datasets is large. Recent methods that address the problem of data scarcity are property augmentation, transfer learning, and semi-supervised learning. A number of web-based applications (e.g., ADMETlab 3.0, admetSAR 3.0, ProTox 3.0) have been published that allow using multi-endpoint prediction with different measures of accuracy and interpretability. DISCUSSION: Traditional ML methods, particularly support vector machines and random forests, remain valuable for smaller datasets due to their robustness and interpretability. However, the adoption of deep learning architectures, such as convolutional and graph neural networks, has markedly improved predictive accuracy when applied to large and complex datasets. CONCLUSIONS: Data-driven methods have significantly advanced toxicity prediction, offering faster and more cost-effective tools compared with traditional assays. However, the field still faces challenges related to limited datasets, variable data quality, and a lack of mechanistic interpretability.

Authors

Institutions

Publication Details

Journal
Current Reviews in Clinical and Experimental Pharmacology
Published
2026-03-31
DOI
https://doi.org/10.2174/0127724328441651260211220550
Primary Topic
Computational Drug Discovery Methods
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Data-Driven Toxicity Prediction: Advances in Machine Learning, DeepLearning, and Predictive Tools - A Systematic Review

Hany Akeel Al-Hussaniy, K. Abdul‐Nabi Ali, Ali Al-Samydai
Current Reviews in Clinical and Experimental Pharmacology
Computational Drug Discovery Methods
article

Data-Driven Toxicity Prediction: Advances in Machine Learning, DeepLearning, and Predictive Tools - A Systematic Review

Hany Akeel Al-Hussaniy, K. Abdul‐Nabi Ali, Ali Al-Samydai
article en

Abstract

INTRODUCTION/OBJECTIVE: High rate of attrition still inhibits drug discovery and development, with toxicity accounting for one of the primary causes of failure in preclinical and clinical development. This review summarizes Machine Learning (ML), Deep Learning (DL), and emerging post-deep learning strategies in drug discovery and environmental safety. METHODS: Following PRISMA guidelines, a systematic search was conducted across PubMed, Web of Science, Scopus, and ScienceDirect for the years 2015-2025, yielding 1,020 articles. Additional records were obtained from Google Scholar and the reference lists of about 60 articles. The studies were included when they used ML/DL to predict toxicity, provided quantitative measures of performance (e.g., accuracy, AUC, F1-score), or when they described the predictive tools and platforms. Eligibility criteria were: the study was entirely experimental toxicology with no computational modeling of the study, lacked an adequate description of the methodology, or was in a non- English language. The last study count of the paper is 50 articles. RESULTS: DL models like convolutional and graph neural networks are more effective in cases when the size of the datasets is large. Recent methods that address the problem of data scarcity are property augmentation, transfer learning, and semi-supervised learning. A number of web-based applications (e.g., ADMETlab 3.0, admetSAR 3.0, ProTox 3.0) have been published that allow using multi-endpoint prediction with different measures of accuracy and interpretability. DISCUSSION: Traditional ML methods, particularly support vector machines and random forests, remain valuable for smaller datasets due to their robustness and interpretability. However, the adoption of deep learning architectures, such as convolutional and graph neural networks, has markedly improved predictive accuracy when applied to large and complex datasets. CONCLUSIONS: Data-driven methods have significantly advanced toxicity prediction, offering faster and more cost-effective tools compared with traditional assays. However, the field still faces challenges related to limited datasets, variable data quality, and a lack of mechanistic interpretability.

Current Reviews in Clinical and Experimental PharmacologyVol. 21
Al-Ahliyya Amman University (JO), Imam Sadiq University (IR), Al-Nisour University College (IQ), Al-Zahra College for Women (OM)
Openalex Percentile: Top 24%
Computational Drug Discovery Methods
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.